OpenSAFELY
Reports

Vaccine Coverage - Second Doses

Description
Monthly* report on COVID-19 vaccination coverage in England focussing on second doses which are due (i.e. where first dose was recorded at least 14 weeks ago). * updates may occasionally be subject to delay.
Contact
Get in touch and tell us how you use this report or new features you'd like to see: [email protected]
First published
02 Jul 2021
Last released
03 May 2022
DOI
http://doi.org/10.53764/rpt.cd7cf36769
Links

OpenSAFELY COVID Vaccine coverage report: Second doses

OpenSAFELY is a new secure analytics platform for electronic patient records built on behalf of NHS England to deliver urgent academic and operational research during the pandemic.

This is an extension of our regular weekly report on COVID-19 vaccination coverage in England using data from 40% of general practices that use TPP electronic health record software. The data requires careful interpretation and there are a number of caveats. Please read the full detail about our methods and discussion of our earlier results (as of 17 March 2021) in our peer-reviewed publication in the British Journal of General Practice.

The full analytical methods behind the latest results in this report are available here.

Update: Our vaccine reports are currently published monthly. If you rely on more regular data updates for your own reporting or analysis please contact [email protected] to let us know.

Second doses

Please note This report is intended to highlight any differences between subgroups of priority cohorts in receiving second doses, only including those which are due (i.e. where at least 14 weeks has passed since the first dose). It is therefore NOT a comprehensive view of all second doses given to date - to see these figures please refer to the main report.

Report last updated 27 Apr 2022

Second dose vaccinations included up to 20 Apr 2022 inclusive

Only persons who had their first dose between the start of the campaign (7 Dec 2020) and 14 weeks ago (12 Jan 2022) are included in the 'due' group.

Group definitions

  • As of 29 Nov 2021, patient age is calculated at 31 Aug 2021 (previously 31 March 2021), in line with national reporting.
  • The care home group is defined based on patients (aged 65+) having one of these codes.
  • The shielding group is defined based on patients (aged 16-69) having one of these codes provided it was not superceded by one of these codes.
  • The LD (learning disability) group is defined based on patients (aged 16-64) having one of these codes and excludes people who are shielding.
  • Patients are counted in their highest risk category only; e.g. a 65-year-old who is shielding is only counted in the shielding group, not in the 65-69 group.
  • The housebound group is defined based on this codelist and excludes people who were later recorded as not housebound or in a care home.

Cumulative second dose vaccination figures among 80+ population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,021,538 6,384 1,015,154 99.4 1,055,649
Sex F 590,569 4,109 586,460 99.3 610,813
M 430,969 2,275 428,694 99.5 444,836
Age band 80-84 552,349 3,143 549,206 99.4 569,513
85-89 320,012 2,100 317,912 99.3 330,295
90+ 149,177 1,141 148,036 99.2 155,834
Ethnicity (broad categories) Black 8,463 238 8,225 97.2 10,570
Mixed 2,730 49 2,681 98.2 3,192
Other 5,656 105 5,551 98.1 6,608
South Asian 24,857 539 24,318 97.8 27,489
Unknown 36,582 287 36,295 99.2 43,148
White 943,250 5,159 938,091 99.5 964,628
ethnicity 16 groups African 1,484 63 1,421 95.8 2,009
Bangladeshi or British Bangladeshi 1,106 35 1,071 96.8 1,253
Caribbean 5,859 133 5,726 97.7 7,147
Chinese 1,414 28 1,386 98.0 1,694
Other 4,249 84 4,165 98.0 4,921
Other Asian 3,801 63 3,738 98.3 4,361
British or Mixed British 896,021 4,676 891,345 99.5 914,235
Indian or British Indian 13,531 217 13,314 98.4 14,504
Irish 8,820 84 8,736 99.0 9,198
Other Black 1,113 35 1,078 96.9 1,414
Other White 38,416 399 38,017 99.0 41,209
Other mixed 1,022 21 1,001 97.9 1,148
Pakistani or British Pakistani 6,419 224 6,195 96.5 7,371
Unknown 36,575 287 36,288 99.2 43,141
White + Asian 476 7 469 98.5 525
White + Black African 280 7 273 97.5 378
White + Black Caribbean 952 21 931 97.8 1,134
Index of Multiple Deprivation (quintiles) 1 Most deprived 125,349 1,127 124,222 99.1 132,748
2 167,699 1,232 166,467 99.3 174,790
3 229,726 1,386 228,340 99.4 236,915
4 239,386 1,309 238,077 99.5 245,826
5 Least deprived 240,184 1,099 239,085 99.5 245,315
Unknown 19,187 231 18,956 98.8 20,055
BMI 30+ 180,432 959 179,473 99.5 184,079
under 30 841,106 5,425 835,681 99.4 871,570
Housebound no 916,993 5,320 911,673 99.4 947,639
yes 104,545 1,064 103,481 99.0 108,010
Chronic cardiac disease no 708,365 4,606 703,759 99.3 735,763
yes 313,173 1,778 311,395 99.4 319,886
Current COPD no 913,955 5,768 908,187 99.4 945,791
yes 107,583 616 106,967 99.4 109,858
DMARDs no 988,932 6,237 982,695 99.4 1,022,525
yes 32,606 147 32,459 99.5 33,117
Dementia no 940,723 5,509 935,214 99.4 972,335
yes 80,815 882 79,933 98.9 83,314
Psychosis, schizophrenia, or bipolar no 1,014,272 6,293 1,007,979 99.4 1,047,942
yes 7,266 91 7,175 98.7 7,707
Learning disability no 1,021,111 6,377 1,014,734 99.4 1,055,194
yes 427 7 420 98.4 448
SSRI (last 12 months) no 980,798 6,118 974,680 99.4 1,014,265
yes 40,740 266 40,474 99.3 41,377
Chemo or radiotherapy no 985,495 6,237 979,258 99.4 1,018,990
yes 36,043 147 35,896 99.6 36,652
Cancer (lung) no 1,014,321 6,342 1,007,979 99.4 1,048,299
yes 7,217 42 7,175 99.4 7,350
Cancer (excluding lung/haem) no 830,368 5,488 824,880 99.3 860,944
yes 191,170 896 190,274 99.5 194,698
Cancer (haematological) no 1,002,015 6,286 995,729 99.4 1,035,790
yes 19,523 98 19,425 99.5 19,852
Chronic kidney disease no 700,406 4,578 695,828 99.3 727,552
yes 321,132 1,806 319,326 99.4 328,097
brand of first dose Moderna 511 336 175 34.2 1,092
Oxford-AZ 269,514 1,981 267,533 99.3 269,514
Pfizer 750,757 4,053 746,704 99.5 751,800
Unknown 756 14 742 98.1 763

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 80+ Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 70-79 population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,009,630 14,847 1,994,783 99.3 2,087,960
Sex F 1,057,161 8,057 1,049,104 99.2 1,097,446
M 952,455 6,783 945,672 99.3 990,500
Age band 70-74 1,147,153 9,548 1,137,605 99.2 1,196,699
75-79 862,463 5,292 857,171 99.4 891,254
Ethnicity (broad categories) Black 11,578 413 11,165 96.4 14,910
Mixed 5,733 119 5,614 97.9 6,699
Other 13,685 371 13,314 97.3 16,296
South Asian 51,744 1,260 50,484 97.6 57,274
Unknown 93,107 882 92,225 99.1 106,428
White 1,833,776 11,802 1,821,974 99.4 1,886,339
ethnicity 16 groups African 4,004 203 3,801 94.9 5,383
Bangladeshi or British Bangladeshi 1,694 70 1,624 95.9 1,932
Caribbean 5,376 154 5,222 97.1 6,762
Chinese 3,612 77 3,535 97.9 4,403
Other 10,066 294 9,772 97.1 11,893
Other Asian 10,395 252 10,143 97.6 11,767
British or Mixed British 1,743,553 10,696 1,732,857 99.4 1,786,372
Indian or British Indian 29,127 560 28,567 98.1 31,458
Irish 14,658 154 14,504 98.9 15,477
Other Black 2,205 70 2,135 96.8 2,765
Other White 75,593 945 74,648 98.7 84,518
Other mixed 2,345 42 2,303 98.2 2,674
Pakistani or British Pakistani 10,514 371 10,143 96.5 12,110
Unknown 93,079 875 92,204 99.1 106,407
White + Asian 1,281 21 1,260 98.4 1,428
White + Black African 882 21 861 97.6 1,099
White + Black Caribbean 1,225 28 1,197 97.7 1,491
Index of Multiple Deprivation (quintiles) 1 Most deprived 253,596 2,408 251,188 99.1 270,032
2 335,328 2,793 332,535 99.2 351,659
3 449,568 3,276 446,292 99.3 466,193
4 468,188 3,066 465,122 99.3 483,231
5 Least deprived 462,756 2,653 460,103 99.4 474,446
Unknown 40,180 644 39,536 98.4 42,392
BMI 30+ 503,909 3,143 500,766 99.4 516,152
under 30 1,505,707 11,690 1,494,017 99.2 1,571,794
Housebound no 1,970,234 14,315 1,955,919 99.3 2,046,996
yes 39,382 525 38,857 98.7 40,950
Chronic cardiac disease no 1,636,040 12,355 1,623,685 99.2 1,704,598
yes 373,576 2,485 371,091 99.3 383,348
Current COPD no 1,816,934 13,587 1,803,347 99.3 1,890,385
yes 192,689 1,260 191,429 99.3 197,561
DMARDs no 1,936,564 14,497 1,922,067 99.3 2,013,550
yes 73,059 350 72,709 99.5 74,396
Dementia no 1,965,971 14,350 1,951,621 99.3 2,043,034
yes 43,645 490 43,155 98.9 44,912
Psychosis, schizophrenia, or bipolar no 1,990,828 14,539 1,976,289 99.3 2,067,772
yes 18,788 301 18,487 98.4 20,174
Learning disability no 2,006,872 14,805 1,992,067 99.3 2,085,076
yes 2,751 42 2,709 98.5 2,870
SSRI (last 12 months) no 1,906,163 14,112 1,892,051 99.3 1,982,638
yes 103,453 728 102,725 99.3 105,308
Chemo or radiotherapy no 1,938,188 14,497 1,923,691 99.3 2,015,174
yes 71,435 350 71,085 99.5 72,772
Cancer (lung) no 1,996,162 14,742 1,981,420 99.3 2,074,212
yes 13,454 98 13,356 99.3 13,734
Cancer (excluding lung/haem) no 1,713,901 13,223 1,700,678 99.2 1,786,022
yes 295,715 1,617 294,098 99.5 301,924
Cancer (haematological) no 1,978,333 14,665 1,963,668 99.3 2,056,012
yes 31,283 175 31,108 99.4 31,941
Chronic kidney disease no 1,743,070 13,244 1,729,826 99.2 1,815,450
yes 266,553 1,603 264,950 99.4 272,496
brand of first dose Moderna 1,981 1,288 693 35.0 2,576
Oxford-AZ 1,204,147 4,641 1,199,506 99.6 1,204,154
Pfizer 801,556 8,876 792,680 98.9 803,103
Unknown 1,939 42 1,897 97.8 1,988

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 70-79 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among care home population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 107,653 2,667 104,986 97.5 112,371
Sex F 75,362 1,806 73,556 97.6 78,414
M 32,284 861 31,423 97.3 33,950
Age band 65-69 6,090 168 5,922 97.2 6,496
70-74 9,695 252 9,443 97.4 10,248
75-79 13,923 371 13,552 97.3 14,630
80-84 19,831 518 19,313 97.4 20,678
85-89 25,788 658 25,130 97.4 26,852
90+ 32,312 679 31,633 97.9 33,460
Ethnicity (broad categories) Black 651 35 616 94.6 756
Mixed 336 7 329 97.9 364
Other 511 14 497 97.3 539
South Asian 1,001 49 952 95.1 1,078
Unknown 1,925 56 1,869 97.1 2,107
White 103,229 2,506 100,723 97.6 107,534
Dementia no 49,154 1,260 47,894 97.4 51,947
yes 58,499 1,407 57,092 97.6 60,417
brand of first dose Moderna 140 98 42 30.0 329
Oxford-AZ 72,016 504 71,512 99.3 72,016
Pfizer 35,308 2,065 33,243 94.2 35,819
Unknown 189 7 182 96.3 189

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population includes those known to live in an elderly care home, based upon clinical coding.

Second Doses Overdue Among Care Home Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among shielding (aged 16-69) population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 753,326 16,961 736,365 97.7 819,854
newly shielded since feb 15 no 451,003 8,064 442,939 98.2 481,684
yes 302,330 8,911 293,419 97.1 338,170
Sex F 424,900 10,115 414,785 97.6 463,022
M 328,419 6,853 321,566 97.9 356,818
Age band 16-29 56,462 2,884 53,578 94.9 66,808
30-39 109,340 4,207 105,133 96.2 125,811
40-49 149,989 3,808 146,181 97.5 164,955
50-59 212,975 3,577 209,398 98.3 227,591
60-69 224,546 2,485 222,061 98.9 234,661
Ethnicity (broad categories) Black 35,350 1,533 33,817 95.7 44,534
Mixed 11,718 462 11,256 96.1 14,280
Other 15,204 504 14,700 96.7 17,983
South Asian 97,965 2,982 94,983 97.0 107,611
Unknown 19,845 371 19,474 98.1 22,386
White 573,237 11,116 562,121 98.1 613,046
Index of Multiple Deprivation (quintiles) 1 Most deprived 211,393 6,433 204,960 97.0 238,245
2 168,105 3,997 164,108 97.6 184,170
3 145,096 2,765 142,331 98.1 156,135
4 116,179 1,932 114,247 98.3 123,032
5 Least deprived 91,910 1,211 90,699 98.7 95,830
Unknown 20,629 623 20,006 97.0 22,421
Learning disability no 727,965 16,408 711,557 97.7 792,932
yes 25,347 553 24,794 97.8 26,901
Chronic kidney disease no 698,957 16,177 682,780 97.7 762,377
yes 54,355 784 53,571 98.6 57,463
brand of first dose Moderna 3,080 1,176 1,904 61.8 3,332
Oxford-AZ 468,706 7,406 461,300 98.4 468,720
Pfizer 280,882 8,344 272,538 97.0 283,234
Unknown 651 42 609 93.5 658

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those over 65 known to live in an elderly care home, based upon clinical coding.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among Shielding (Aged 16-69) Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 65-69 population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,024,604 12,166 1,012,438 98.8 1,091,279
Sex F 527,513 6,349 521,164 98.8 559,342
M 497,084 5,817 491,267 98.8 531,930
Ethnicity (broad categories) Black 8,904 336 8,568 96.2 11,746
Mixed 4,333 112 4,221 97.4 5,236
Other 10,360 329 10,031 96.8 12,943
South Asian 41,202 1,239 39,963 97.0 46,109
Unknown 63,525 854 62,671 98.7 76,062
White 896,280 9,303 886,977 99.0 939,183
ethnicity 16 groups African 3,507 168 3,339 95.2 4,655
Bangladeshi or British Bangladeshi 1,743 56 1,687 96.8 1,932
Caribbean 3,479 105 3,374 97.0 4,662
Chinese 3,339 105 3,234 96.9 4,200
Other 7,014 217 6,797 96.9 8,743
Other Asian 7,665 224 7,441 97.1 8,771
British or Mixed British 847,175 8,253 838,922 99.0 879,123
Indian or British Indian 22,008 581 21,427 97.4 24,073
Irish 6,391 126 6,265 98.0 6,916
Other Black 1,925 63 1,862 96.7 2,429
Other White 42,728 931 41,797 97.8 53,165
Other mixed 1,701 42 1,659 97.5 2,044
Pakistani or British Pakistani 9,779 378 9,401 96.1 11,333
Unknown 63,511 847 62,664 98.7 76,048
White + Asian 966 21 945 97.8 1,078
White + Black African 721 21 700 97.1 938
White + Black Caribbean 945 28 917 97.0 1,169
Index of Multiple Deprivation (quintiles) 1 Most deprived 139,370 2,114 137,256 98.5 154,686
2 177,177 2,317 174,860 98.7 191,562
3 227,458 2,646 224,812 98.8 241,458
4 232,309 2,450 229,859 98.9 244,237
5 Least deprived 225,554 2,065 223,489 99.1 234,794
Unknown 22,736 588 22,148 97.4 24,535
BMI 30+ 265,111 2,688 262,423 99.0 275,338
under 30 759,493 9,485 750,008 98.8 815,934
Housebound no 1,019,746 12,068 1,007,678 98.8 1,086,043
yes 4,851 98 4,753 98.0 5,229
Chronic cardiac disease no 911,757 10,913 900,844 98.8 973,476
yes 112,840 1,246 111,594 98.9 117,796
Current COPD no 983,822 11,676 972,146 98.8 1,048,474
yes 40,775 490 40,285 98.8 42,805
DMARDs no 1,004,143 11,991 992,152 98.8 1,070,160
yes 20,454 175 20,279 99.1 21,112
Dementia no 1,018,647 12,082 1,006,565 98.8 1,085,021
yes 5,950 84 5,866 98.6 6,258
Psychosis, schizophrenia, or bipolar no 1,014,013 11,935 1,002,078 98.8 1,079,491
yes 10,584 224 10,360 97.9 11,788
Learning disability no 1,022,266 12,131 1,010,135 98.8 1,088,780
yes 2,331 35 2,296 98.5 2,492
SSRI (last 12 months) no 963,949 11,480 952,469 98.8 1,028,755
yes 60,655 686 59,969 98.9 62,524
Chemo or radiotherapy no 1,004,080 11,991 992,089 98.8 1,070,076
yes 20,524 182 20,342 99.1 21,196
Cancer (lung) no 1,022,350 12,145 1,010,205 98.8 1,088,920
yes 2,247 21 2,226 99.1 2,359
Cancer (excluding lung/haem) no 933,037 11,354 921,683 98.8 996,527
yes 91,567 819 90,748 99.1 94,752
Cancer (haematological) no 1,020,579 12,117 1,008,462 98.8 1,087,079
yes 4,018 42 3,976 99.0 4,193
Chronic kidney disease no 973,630 11,620 962,010 98.8 1,038,436
yes 50,974 546 50,428 98.9 52,836
brand of first dose Moderna 2,198 1,568 630 28.7 2,359
Oxford-AZ 676,361 3,647 672,714 99.5 676,361
Pfizer 344,841 6,909 337,932 98.0 345,723
Unknown 1,204 49 1,155 95.9 1,239

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those known to live in an elderly care home, based upon clinical coding.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 65-69 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among Learning Disabilities (aged 16-64) population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 75,859 2,800 73,059 96.3 86,079
Sex F 29,225 959 28,266 96.7 32,508
M 46,627 1,841 44,786 96.1 53,564
Age band 16-17 3,808 406 3,402 89.3 5,047
18-29 26,481 1,197 25,284 95.5 31,199
30-34 9,772 357 9,415 96.3 11,193
35-39 7,273 231 7,042 96.8 8,099
40-44 5,796 168 5,628 97.1 6,321
45-49 5,677 133 5,544 97.7 6,097
50-54 6,174 112 6,062 98.2 6,587
55-59 6,153 105 6,048 98.3 6,566
60-64 4,718 77 4,641 98.4 4,977
Ethnicity (broad categories) Black 987 77 910 92.2 1,484
Mixed 903 49 854 94.6 1,204
Other 623 28 595 95.5 798
South Asian 4,137 266 3,871 93.6 5,054
Unknown 4,585 140 4,445 96.9 5,306
White 64,624 2,247 62,377 96.5 72,233
brand of first dose Moderna 588 182 406 69.0 644
Oxford-AZ 49,686 980 48,706 98.0 49,686
Pfizer 25,536 1,638 23,898 93.6 26,005
Unknown 49 0 49 100.0 49

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.

Second Doses Overdue Among People With Learning Disabilities (Aged 16-64)

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 60-64 population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,210,860 17,157 1,193,703 98.6 1,311,590
Sex F 610,701 8,652 602,049 98.6 654,843
M 600,152 8,512 591,640 98.6 656,740
Ethnicity (broad categories) Black 15,365 581 14,784 96.2 20,895
Mixed 6,923 203 6,720 97.1 8,512
Other 14,000 455 13,545 96.8 17,955
South Asian 48,846 1,358 47,488 97.2 55,202
Unknown 88,102 1,246 86,856 98.6 107,541
White 1,037,617 13,314 1,024,303 98.7 1,101,478
ethnicity 16 groups African 6,111 238 5,873 96.1 8,050
Bangladeshi or British Bangladeshi 2,198 77 2,121 96.5 2,450
Caribbean 5,670 217 5,453 96.2 8,141
Chinese 4,368 161 4,207 96.3 5,439
Other 9,632 301 9,331 96.9 12,509
Other Asian 10,416 294 10,122 97.2 11,991
British or Mixed British 974,715 11,788 962,927 98.8 1,020,684
Indian or British Indian 24,990 609 24,381 97.6 27,699
Irish 6,314 126 6,188 98.0 6,979
Other Black 3,584 126 3,458 96.5 4,704
Other White 56,581 1,407 55,174 97.5 73,808
Other mixed 2,632 77 2,555 97.1 3,262
Pakistani or British Pakistani 11,235 371 10,864 96.7 13,062
Unknown 88,102 1,246 86,856 98.6 107,534
White + Asian 1,414 21 1,393 98.5 1,596
White + Black African 1,281 49 1,232 96.2 1,589
White + Black Caribbean 1,610 63 1,547 96.1 2,079
Index of Multiple Deprivation (quintiles) 1 Most deprived 176,246 3,360 172,886 98.1 201,502
2 214,690 3,360 211,330 98.4 236,859
3 265,314 3,549 261,765 98.7 285,887
4 269,437 3,325 266,112 98.8 286,874
5 Least deprived 257,712 2,737 254,975 98.9 270,459
Unknown 27,454 826 26,628 97.0 29,995
BMI 30+ 308,000 3,822 304,178 98.8 322,623
under 30 902,853 13,335 889,518 98.5 988,960
Chronic cardiac disease no 1,115,093 15,904 1,099,189 98.6 1,210,440
yes 95,760 1,260 94,500 98.7 101,143
Current COPD no 1,175,678 16,555 1,159,123 98.6 1,274,154
yes 35,175 602 34,573 98.3 37,429
DMARDs no 1,189,398 16,940 1,172,458 98.6 1,289,211
yes 21,455 217 21,238 99.0 22,372
Dementia no 1,206,996 17,094 1,189,902 98.6 1,307,509
yes 3,857 70 3,787 98.2 4,074
Psychosis, schizophrenia, or bipolar no 1,197,371 16,779 1,180,592 98.6 1,296,253
yes 13,482 378 13,104 97.2 15,330
SSRI (last 12 months) no 1,127,980 15,974 1,112,006 98.6 1,225,252
yes 82,873 1,183 81,690 98.6 86,331
Chemo or radiotherapy no 1,192,086 16,968 1,175,118 98.6 1,292,095
yes 18,767 189 18,578 99.0 19,488
Cancer (lung) no 1,209,355 17,136 1,192,219 98.6 1,309,973
yes 1,498 21 1,477 98.6 1,610
Cancer (excluding lung/haem) no 1,134,875 16,331 1,118,544 98.6 1,232,245
yes 75,978 833 75,145 98.9 79,338
Cancer (haematological) no 1,207,255 17,115 1,190,140 98.6 1,307,775
yes 3,598 42 3,556 98.8 3,808
Chronic kidney disease no 1,178,247 16,758 1,161,489 98.6 1,277,360
yes 32,606 399 32,207 98.8 34,223
brand of first dose Moderna 3,836 2,590 1,246 32.5 4,074
Oxford-AZ 886,424 6,055 880,369 99.3 886,445
Pfizer 319,221 8,435 310,786 97.4 320,754
Unknown 1,372 77 1,295 94.4 1,400

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 60-64 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 55-59 population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,396,906 23,065 1,373,841 98.3 1,544,088
Sex F 700,553 11,067 689,486 98.4 760,158
M 696,346 12,005 684,341 98.3 783,923
Ethnicity (broad categories) Black 24,101 1,022 23,079 95.8 33,229
Mixed 10,402 329 10,073 96.8 13,083
Other 18,606 651 17,955 96.5 24,381
South Asian 55,510 1,505 54,005 97.3 63,497
Unknown 106,820 1,785 105,035 98.3 135,387
White 1,181,453 17,766 1,163,687 98.5 1,274,504
ethnicity 16 groups African 10,409 441 9,968 95.8 13,790
Bangladeshi or British Bangladeshi 2,856 70 2,786 97.5 3,192
Caribbean 7,490 357 7,133 95.2 11,151
Chinese 5,621 210 5,411 96.3 7,035
Other 12,985 441 12,544 96.6 17,339
Other Asian 13,650 392 13,258 97.1 15,967
British or Mixed British 1,103,333 15,708 1,087,625 98.6 1,170,687
Indian or British Indian 26,649 623 26,026 97.7 29,785
Irish 7,315 175 7,140 97.6 8,316
Other Black 6,202 224 5,978 96.4 8,302
Other White 70,847 1,876 68,971 97.4 95,550
Other mixed 3,717 105 3,612 97.2 4,704
Pakistani or British Pakistani 12,341 413 11,928 96.7 14,539
Unknown 106,785 1,785 105,000 98.3 135,331
White + Asian 2,135 56 2,079 97.4 2,450
White + Black African 1,953 70 1,883 96.4 2,499
White + Black Caribbean 2,597 98 2,499 96.2 3,430
Index of Multiple Deprivation (quintiles) 1 Most deprived 212,093 5,054 207,039 97.6 249,585
2 249,256 4,732 244,524 98.1 281,904
3 302,498 4,844 297,654 98.4 332,430
4 306,579 4,214 302,365 98.6 331,576
5 Least deprived 295,239 3,360 291,879 98.9 313,943
Unknown 31,227 854 30,373 97.3 34,650
BMI 30+ 342,167 4,816 337,351 98.6 362,467
under 30 1,054,732 18,249 1,036,483 98.3 1,181,607
Chronic cardiac disease no 1,324,260 21,826 1,302,434 98.4 1,466,171
yes 72,632 1,232 71,400 98.3 77,903
Current COPD no 1,369,347 22,435 1,346,912 98.4 1,514,100
yes 27,552 637 26,915 97.7 29,981
DMARDs no 1,375,318 22,813 1,352,505 98.3 1,521,352
yes 21,581 252 21,329 98.8 22,722
Psychosis, schizophrenia, or bipolar no 1,380,162 22,477 1,357,685 98.4 1,524,621
yes 16,737 588 16,149 96.5 19,453
SSRI (last 12 months) no 1,292,144 21,392 1,270,752 98.3 1,434,083
yes 104,748 1,673 103,075 98.4 109,991
Chronic kidney disease no 1,375,101 22,778 1,352,323 98.3 1,520,855
yes 21,798 287 21,511 98.7 23,219
brand of first dose Moderna 5,418 3,178 2,240 41.3 5,754
Oxford-AZ 1,079,946 9,226 1,070,720 99.1 1,079,974
Pfizer 310,142 10,563 299,579 96.6 312,508
Unknown 1,386 98 1,288 92.9 1,428

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 55-59 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 50-54 population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 1,401,463 28,014 1,373,449 98.0 1,588,734
Sex F 704,319 12,754 691,565 98.2 775,775
M 697,130 15,260 681,870 97.8 812,952
Ethnicity (broad categories) Black 27,874 1,330 26,544 95.2 38,997
Mixed 12,404 455 11,949 96.3 16,065
Other 23,688 945 22,743 96.0 31,766
South Asian 78,183 2,394 75,789 96.9 91,014
Unknown 114,527 2,219 112,308 98.1 149,261
White 1,144,773 20,671 1,124,102 98.2 1,261,610
ethnicity 16 groups African 15,372 721 14,651 95.3 20,531
Bangladeshi or British Bangladeshi 4,753 119 4,634 97.5 5,299
Caribbean 5,866 301 5,565 94.9 9,303
Chinese 6,489 252 6,237 96.1 8,225
Other 17,199 686 16,513 96.0 23,548
Other Asian 19,082 602 18,480 96.8 22,673
British or Mixed British 1,052,219 17,766 1,034,453 98.3 1,131,788
Indian or British Indian 33,047 826 32,221 97.5 37,548
Irish 7,119 203 6,916 97.1 8,337
Other Black 6,636 308 6,328 95.4 9,170
Other White 85,442 2,709 82,733 96.8 121,485
Other mixed 4,529 182 4,347 96.0 5,999
Pakistani or British Pakistani 21,301 847 20,454 96.0 25,487
Unknown 114,534 2,219 112,315 98.1 149,261
White + Asian 2,681 70 2,611 97.4 3,143
White + Black African 2,625 105 2,520 96.0 3,437
White + Black Caribbean 2,569 105 2,464 95.9 3,479
Index of Multiple Deprivation (quintiles) 1 Most deprived 225,589 7,021 218,568 96.9 276,367
2 255,269 6,006 249,263 97.6 297,731
3 296,492 5,544 290,948 98.1 333,830
4 300,496 4,830 295,666 98.4 330,820
5 Least deprived 291,256 3,682 287,574 98.7 313,369
Unknown 32,347 924 31,423 97.1 36,603
BMI 30+ 330,197 5,509 324,688 98.3 354,081
under 30 1,071,252 22,505 1,048,747 97.9 1,234,639
Chronic cardiac disease no 1,354,234 26,943 1,327,291 98.0 1,536,941
yes 47,215 1,064 46,151 97.7 51,779
Current COPD no 1,383,396 27,482 1,355,914 98.0 1,568,630
yes 18,053 525 17,528 97.1 20,090
DMARDs no 1,382,724 27,762 1,354,962 98.0 1,568,763
yes 18,725 245 18,480 98.7 19,957
Psychosis, schizophrenia, or bipolar no 1,384,523 27,307 1,357,216 98.0 1,568,343
yes 16,926 707 16,219 95.8 20,377
SSRI (last 12 months) no 1,289,974 25,928 1,264,046 98.0 1,470,658
yes 111,482 2,086 109,396 98.1 118,062
Chronic kidney disease no 1,389,430 27,790 1,361,640 98.0 1,575,700
yes 12,026 224 11,802 98.1 13,027
brand of first dose Moderna 9,786 3,367 6,419 65.6 10,241
Oxford-AZ 1,103,158 12,075 1,091,083 98.9 1,103,186
Pfizer 287,000 12,439 274,561 95.7 290,297
Unknown 1,512 133 1,379 91.2 1,547

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • Population excludes those who are shielding.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 50-54 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 40-49 population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,435,545 74,858 2,360,687 96.9 3,005,037
Sex F 1,231,811 32,774 1,199,037 97.3 1,436,400
M 1,203,699 42,084 1,161,615 96.5 1,568,581
Ethnicity (broad categories) Black 63,616 3,605 60,011 94.3 95,004
Mixed 31,059 1,505 29,554 95.2 43,939
Other 65,016 3,080 61,936 95.3 95,781
South Asian 220,269 8,974 211,295 95.9 278,089
Unknown 186,375 5,873 180,502 96.8 276,143
White 1,869,168 51,814 1,817,354 97.2 2,216,032
ethnicity 16 groups African 42,329 2,303 40,026 94.6 60,102
Bangladeshi or British Bangladeshi 16,275 602 15,673 96.3 19,425
Caribbean 7,798 511 7,287 93.4 14,749
Chinese 17,241 798 16,443 95.4 24,094
Other 47,775 2,275 45,500 95.2 71,687
Other Asian 51,576 2,079 49,497 96.0 66,360
British or Mixed British 1,633,317 42,637 1,590,680 97.4 1,833,853
Indian or British Indian 91,609 2,961 88,648 96.8 115,087
Irish 11,669 441 11,228 96.2 15,141
Other Black 13,489 791 12,698 94.1 20,153
Other White 224,224 8,736 215,488 96.1 367,080
Other mixed 12,047 588 11,459 95.1 17,542
Pakistani or British Pakistani 60,802 3,339 57,463 94.5 77,210
Unknown 186,354 5,880 180,474 96.8 276,108
White + Asian 6,790 238 6,552 96.5 8,673
White + Black African 7,315 378 6,937 94.8 10,164
White + Black Caribbean 4,914 308 4,606 93.7 7,560
Index of Multiple Deprivation (quintiles) 1 Most deprived 421,743 21,070 400,673 95.0 581,406
2 454,013 16,317 437,696 96.4 587,202
3 501,445 14,084 487,361 97.2 615,370
4 498,792 11,585 487,207 97.7 587,265
5 Least deprived 488,292 9,107 479,185 98.1 549,675
Unknown 71,225 2,695 68,530 96.2 84,056
BMI 30+ 469,847 12,103 457,744 97.4 525,161
under 30 1,965,663 62,762 1,902,901 96.8 2,479,820
Chronic cardiac disease no 2,397,857 73,591 2,324,266 96.9 2,961,735
yes 37,646 1,267 36,379 96.6 43,239
Current COPD no 2,421,447 74,193 2,347,254 96.9 2,988,370
yes 14,063 672 13,391 95.2 16,604
DMARDs no 2,410,604 74,382 2,336,222 96.9 2,977,450
yes 24,906 476 24,430 98.1 27,524
Psychosis, schizophrenia, or bipolar no 2,405,130 73,136 2,331,994 97.0 2,966,782
yes 30,380 1,722 28,658 94.3 38,199
SSRI (last 12 months) no 2,262,435 69,594 2,192,841 96.9 2,814,896
yes 173,075 5,264 167,811 97.0 190,085
Chronic kidney disease no 2,425,101 74,585 2,350,516 96.9 2,993,354
yes 10,402 266 10,136 97.4 11,627
brand of first dose Moderna 91,700 8,708 82,992 90.5 93,345
Oxford-AZ 1,666,014 25,809 1,640,205 98.5 1,666,098
Pfizer 674,548 39,914 634,634 94.1 685,937
Unknown 3,248 427 2,821 86.9 3,297

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.
  • SSRIs group excludes individuals with Psychosis/ schizophrenia/bipolar, LD, or Dementia.
  • Chronic kidney disease is defined as the presence of a relevant diagnostic code, or a most recent stage recorded >= 3.

Second Doses Overdue Among 40-49 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 30-39 population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,446,045 129,885 2,316,160 94.7 3,410,428
Sex F 1,260,189 59,577 1,200,612 95.3 1,648,038
M 1,185,779 70,301 1,115,478 94.1 1,762,278
Ethnicity (broad categories) Black 57,071 5,628 51,443 90.1 103,474
Mixed 38,983 2,884 36,099 92.6 64,526
Other 72,765 5,201 67,564 92.9 127,253
South Asian 245,721 16,219 229,502 93.4 353,185
Unknown 188,839 10,136 178,703 94.6 304,871
White 1,842,589 89,810 1,752,779 95.1 2,457,000
ethnicity 16 groups African 38,759 3,710 35,049 90.4 65,114
Bangladeshi or British Bangladeshi 17,150 1,029 16,121 94.0 23,198
Caribbean 6,622 700 5,922 89.4 16,275
Chinese 17,794 1,022 16,772 94.3 32,578
Other 54,978 4,179 50,799 92.4 94,696
Other Asian 54,768 3,899 50,869 92.9 80,696
British or Mixed British 1,576,526 73,787 1,502,739 95.3 1,924,195
Indian or British Indian 104,923 5,880 99,043 94.4 151,389
Irish 10,955 665 10,290 93.9 17,010
Other Black 11,683 1,211 10,472 89.6 22,071
Other White 255,066 15,351 239,715 94.0 515,746
Other mixed 15,729 1,085 14,644 93.1 26,292
Pakistani or British Pakistani 68,887 5,404 63,483 92.2 97,930
Unknown 188,874 10,150 178,724 94.6 304,906
White + Asian 8,708 518 8,190 94.1 12,439
White + Black African 7,105 567 6,538 92.0 11,487
White + Black Caribbean 7,434 714 6,720 90.4 14,301
Index of Multiple Deprivation (quintiles) 1 Most deprived 475,783 36,603 439,180 92.3 761,390
2 495,243 29,239 466,004 94.1 730,744
3 503,958 24,479 479,479 95.1 693,812
4 462,672 19,579 443,093 95.8 599,669
5 Least deprived 396,613 14,273 382,340 96.4 486,017
Unknown 111,706 5,712 105,994 94.9 138,684
brand of first dose Moderna 155,596 17,227 138,369 88.9 159,551
Oxford-AZ 547,575 13,363 534,212 97.6 547,610
Pfizer 1,738,443 98,560 1,639,883 94.3 1,767,227
Unknown 4,361 735 3,626 83.1 4,417

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 30-39 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 18-29 population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 2,469,782 202,951 2,266,831 91.8 3,548,622
Sex F 1,260,770 95,760 1,165,010 92.4 1,750,112
M 1,208,809 107,177 1,101,632 91.1 1,798,216
Ethnicity (broad categories) Black 52,556 8,176 44,380 84.4 109,004
Mixed 46,557 5,383 41,174 88.4 80,479
Other 74,144 11,151 62,993 85.0 152,572
South Asian 214,641 22,855 191,786 89.4 326,963
Unknown 335,356 22,358 312,998 93.3 496,580
White 1,746,325 133,014 1,613,311 92.4 2,382,737
ethnicity 16 groups African 33,733 5,334 28,399 84.2 65,870
Bangladeshi or British Bangladeshi 17,213 1,778 15,435 89.7 24,703
Caribbean 6,524 910 5,614 86.1 16,856
Chinese 27,615 5,369 22,246 80.6 62,118
Other 46,522 5,789 40,733 87.6 90,426
Other Asian 47,719 5,404 42,315 88.7 75,201
British or Mixed British 1,567,895 115,080 1,452,815 92.7 1,990,800
Indian or British Indian 86,751 8,078 78,673 90.7 125,776
Irish 8,260 889 7,371 89.2 13,475
Other Black 12,292 1,932 10,360 84.3 26,271
Other White 170,254 17,052 153,202 90.0 378,581
Other mixed 17,115 1,939 15,176 88.7 30,219
Pakistani or British Pakistani 62,944 7,588 55,356 87.9 101,255
Unknown 335,293 22,351 312,942 93.3 496,517
White + Asian 12,068 1,197 10,871 90.1 17,626
White + Black African 7,420 1,008 6,412 86.4 13,293
White + Black Caribbean 9,947 1,232 8,715 87.6 19,355
Index of Multiple Deprivation (quintiles) 1 Most deprived 476,770 53,606 423,164 88.8 804,699
2 505,981 45,808 460,173 90.9 764,106
3 513,779 39,767 474,012 92.3 717,892
4 467,201 32,389 434,812 93.1 617,967
5 Least deprived 409,444 23,471 385,973 94.3 513,576
Unknown 96,390 7,882 88,508 91.8 130,095
brand of first dose Moderna 190,057 29,064 160,993 84.7 198,205
Oxford-AZ 345,800 10,311 335,489 97.0 345,842
Pfizer 1,928,416 162,834 1,765,582 91.6 1,985,508
Unknown 5,299 714 4,585 86.5 5,369

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 18-29 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Cumulative second dose vaccination figures among 16-17 population

Please refer to footnotes below table for information.

Second Doses due at 20 Apr 2022 (n) Second doses overdue (n) Second doses given (n) Second doses given (% of due) Total population
Category Group
overall overall 361,018 66,360 294,658 81.6 538,566
Sex F 182,707 32,165 150,542 82.4 263,459
M 178,276 34,181 144,095 80.8 275,065
Ethnicity (broad categories) Black 6,440 2,219 4,221 65.5 17,696
Mixed 7,504 1,722 5,782 77.1 14,546
Other 7,056 1,533 5,523 78.3 14,945
South Asian 26,607 6,482 20,125 75.6 45,794
Unknown 68,558 11,424 57,134 83.3 100,016
White 244,818 42,966 201,852 82.4 345,527
Index of Multiple Deprivation (quintiles) 1 Most deprived 62,153 17,339 44,814 72.1 121,898
2 62,762 13,797 48,965 78.0 101,724
3 72,107 12,908 59,199 82.1 103,292
4 75,383 11,060 64,323 85.3 100,100
5 Least deprived 80,409 9,681 70,728 88.0 99,414
Unknown 8,176 1,561 6,615 80.9 12,096
brand of first dose Moderna 1,141 595 546 47.9 1,589
Oxford-AZ 1,995 84 1,911 95.8 2,002
Pfizer 357,735 65,667 292,068 81.6 375,557
Unknown 119 14 105 88.2 119

Footnotes:

  • Patient counts rounded to the nearest 7.
  • Only persons who are currently registered and had their first dose at least 14 weeks ago are included in the 'due' group.

Second Doses Overdue Among 16-17 Population

Second doses which have not been given at least 14 weeks since the first dose

Error bars indicate possible error caused by rounding

Summary

Second Doses due at 20 Apr 2022 (n) Second doses given (% of due) Second doses given (n) Second doses overdue (n) Total population
80+ 1,021,538 99.4 1,015,154 6,384 1,055,649
70-79 2,009,630 99.3 1,994,783 14,847 2,087,960
care home 107,653 97.5 104,986 2,667 112,371
shielding (aged 16-69) 753,326 97.7 736,365 16,961 819,854
65-69 1,024,604 98.8 1,012,438 12,166 1,091,279
LD (aged 16-64) 75,859 96.3 73,059 2,800 86,079
60-64 1,210,860 98.6 1,193,703 17,157 1,311,590
55-59 1,396,906 98.3 1,373,841 23,065 1,544,088
50-54 1,401,463 98.0 1,373,449 28,014 1,588,734
40-49 2,435,545 96.9 2,360,687 74,858 3,005,037
30-39 2,446,045 94.7 2,316,160 129,885 3,410,428
18-29 2,469,782 91.8 2,266,831 202,951 3,548,622
16-17 361,018 81.6 294,658 66,360 538,566